Recent Material Events - Barr Pharmaceuticals, Inc. (BRL)

Filing Date	Description
2008-11-21	On November 21, 2008, the shareholders of Barr Pharmaceuticals, Inc. voted to adopt the Agreement and Plan of Merger, dated July 17, 2008, by and among Barr Pharmaceuticals, Inc. (“Barr”), Teva Pharmaceutical Industries Limited (“Teva& ...
2008-11-06	On November 6, 2008, Barr Pharmaceuticals, Inc. (the “Company”) issued a press release announcing results for the quarter ended September 30, 2008. A copy of the release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K ...
2008-10-29	On October 27, 2008, Barr Pharmaceuticals, Inc. announced that Barr and certain of its subsidiaries (as guarantors), Barr Laboratories, Inc., as borrower (the “Borrower”), Bank of America, N.A., as Administrative Agent, and the other lender ...
2008-08-07	On August 7, 2008, Barr Pharmaceuticals, Inc. (the “Company”) issued a press release announcing results for the quarter ended June 30, 2008. A copy of the release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is ...
2008-07-18	On July 15, 2008, Barr Pharmaceuticals, Inc. (the “Company”) entered into amended and restated employment agreements (the “ Amended Agreements ”) with the following executive officers of the Company: Bruce L. Downey, the Company&# ...
2008-07-18	On July 18, 2008, Barr Pharmaceuticals, Inc. (the “ Company ”) and Teva Pharmaceutical Industries (“ Teva ”) issued a joint press release announcing that they have entered into a definitive Agreement and Plan of Merger (the “ ...
2008-06-23	On June 19, 2008, Barr Pharmaceuticals, Inc. (the “Company”) and certain of the Company’s subsidiaries (as guarantors), Barr Laboratories, Inc., as borrower (the “Borrower”), Bank of America, N.A., as Administrative Agent, Ba ...
2008-05-08	On May 8, 2008, Barr Pharmaceuticals, Inc. (the “Company”) issued a press release announcing results for the quarter ended March 31, 2008. A copy of the release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is in ...
2008-03-07	On March 4, 2008, Barr Pharmaceuticals, Inc. (the “Company”) appointed Sigurd Kirk, the Company’s Senior Vice President and Corporate Controller, as the Company’s Chief Accounting Officer. This responsibility was previously handle ...
2008-02-28	On February 28, 2008, Barr Pharmaceuticals, Inc. (the “Company”) issued a press release announcing results for the fourth quarter and full year 2007, each ended December 31, 2007. A copy of the release is being furnished as Exhibit 99.1 to ...